Portfolio

A balanced portfolio built on the cornerstones of diversification and selectivity

Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.

Key portfolio statistics

$2.1B
Investment portfolio at fair value1
91%
First-lien term loans2
210
Portfolio companies
0.5%
Average position size
$76M
Weight average annual EBITDA3

As of March 31, 2054

For complete information regarding our financials, see our periodic filings.

1. RRepresents total investment portfolio at fair value. Total par value of debt investment commitments is $2,336M which includes approximately $246M of unfunded debt investment commitments.
2. First lien debt is comprised of 68% traditional first lien positions and 32% unitranche positions.
3. Weighted based on fair market value of private debt investments as of March 31, 2025 for which fair value is determined in good faith by the Company’s investment adviser, as the valuation designee subject to the oversight of our board of directors, and excludes quoted assets. Amounts are weighted based on fair market value of each respective investment as of its most recent quarterly valuation, which are derived from the most recently available portfolio company financial statements. EBITDA is a non-GAAP financial measure. For a particular portfolio company, EBITDA is generally defined as net income before net interest expense, income tax expense, depreciation and amortization. EBITDA amounts are estimated from the most recent portfolio company financial statements, have not been independently verified by the Company and may reflect a normalized or adjusted amount. Accordingly, the Company makes no representation or warranty in respect of this information.


View reconciliation

Portfolio composition

Portfolio diversification by industry*

Industry

%

Healthcare & Pharmaceuticals 16.5%
Services: Business 16.3%
Beverage, Food & Tobacco 7.5%
High Tech Industries 6.8%
Construction & Building 6.4%
Capital Equipment 5.0%
Services: Consumer 5.0%
Environmental Industries 3.9%
Banking, Finance, Insurance & Real Estate 3.5%
Containers, Packaging & Glass 3.5%
Other (16) 25.7%
Total 100%

As of March 31, 2025

For complete information regarding our financials, see our periodic filings.

* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.

Portfolio composition by investment type

Investment type

%

First Lien Term Loan (including DDTLs)** 91%
Subordinated Debt 8%
Equity 2%
Total 100%

As of March 31, 2025

For complete information regarding our financials, see our periodic filings.

** First lien debt is comprised of 68% traditional first lien positions and 32% unitranche positions.

Portfolio composition by issuer concentration (at Fair Value)

Portfolio Company

%

S&S Truck Parts 1.5%
Trilon Group 1.4%
MGM Transformer Company 1.4%
Good2Grow 1.3%
North Haven CS Acquisition, Inc. 1.3%
Insulation Technology Group 1.3%
Specialized Packaging Group (SPG) 1.2%
Handgards, LLC 1.2%
GHR Healthcare 1.2%
Kenco 1.1%
Others (200) 87.1%
Total 100%

As of March 31, 2025

For complete information regarding our financials, see our periodic filings.

% of debt investments with floating rate

Floating Rate

%

Floating rate 94.6%
Fixed rate 5.5%
Total 100%

As of March 31, 2025

For complete information regarding our financials, see our periodic filings.

Portfolio holdings

Top ten positions

Lead Left Arranger

Senior Secured Credit Facility
 

2022

Lead Left Arranger

Unitranche Credit Facility
 

2022

Sole Lead Arranger

Senior Secured Credit Facility
 

2023

Lead Left Arranger

First Lien Credit Facility
 

2022

Lender

Unitranche Credit Facility
 

2019

Lead Left Arranger

Senior Secured Credit Facility
 

2024

Co-Lead Arranger

Senior Secured Credit Facility
Equity

2020

Sole Lead Arranger

Senior Secured Credit Facility
 

2024

Lead Left Arranger

Senior Secured Credit Facility
 

2024

Lead Left Arranger

Senior Secured Credit Facility
 

2022

Represents the top ten positions in NCDL based on Fair Value as of March 31, 2025

Filter by:

Download schedule of investments
Company Fair value ($ in thousands) Industry Asset Types Pricing1
Bridges Consumer Healthcare Intermediate LLC 2,180,642 Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.25%
Bridges Consumer Healthcare Intermediate LLC 5,742,209 Healthcare & Pharmaceuticals First Lien Debt S + 5.25%
Coding Solutions Acquisition, Inc. 12,222,184 Healthcare & Pharmaceuticals First Lien Debt S + 5.00%
Coding Solutions Acquisition, Inc. (5,326) Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.00%
GHR Healthcare, LLC 6,097,883 Healthcare & Pharmaceuticals First Lien Debt S + 5.25%
Promptcare Infusion Buyer, Inc. 1,261,603 Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 6.00%
VMG Holdings LLC (VMG Health) 1,128,436 Healthcare & Pharmaceuticals First Lien Debt S + 4.75%
VMG Holdings LLC (VMG Health) 15,709,503 Healthcare & Pharmaceuticals First Lien Debt S + 4.75%
Tidi Legacy Products, Inc. 33,465 Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.25%
Tidi Legacy Products, Inc. 15,454,246 Healthcare & Pharmaceuticals First Lien Debt S + 5.25%
TBRS, Inc. 8,002,388 Healthcare & Pharmaceuticals First Lien Debt S + 4.75%
Wellspring Pharmaceutical Corporation 3,330,709 Healthcare & Pharmaceuticals First Lien Debt S + 5.00%
Wellspring Pharmaceutical Corporation 1,549,075 Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.00%
YI, LLC (Young Innovations) (44,828) Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.75%
YI, LLC (Young Innovations) 16,132,345 Healthcare & Pharmaceuticals First Lien Debt S + 5.75%
Wellspring Pharmaceutical Corporation 1,228,449 Healthcare & Pharmaceuticals First Lien Debt S + 5.00%
Wellspring Pharmaceutical Corporation 2,548,642 Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.00%
TBRS, Inc. 70,742 Healthcare & Pharmaceuticals Revolving Loan S + 4.75%
Wellspring Pharmaceutical Corporation 7,282,992 Healthcare & Pharmaceuticals First Lien Debt S + 5.00%
QHR Health, LLC 3,206,880 Healthcare & Pharmaceuticals First Lien Debt S + 5.25%
RCP Nats Co-Investment Fund LP 1,000,000 Healthcare & Pharmaceuticals Equity Investment
QHR Health, LLC 3,206,880 Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 5.25%
QHR Health, LLC 7,581,316 Healthcare & Pharmaceuticals First Lien Debt S + 5.25%
TBRS, Inc. (21,431) Healthcare & Pharmaceuticals First Lien Debt (Delayed Draw) S + 4.75%
REP Coinvest III AAD, L.P. (Anne Arundel) - Healthcare & Pharmaceuticals Equity Investment
Promptcare Infusion Buyer, Inc. 8,098,860 Healthcare & Pharmaceuticals First Lien Debt S + 6.00%
SM Wellness Holdings, Inc. (Solis Mammography) 12,891,154 Healthcare & Pharmaceuticals First Lien Debt S + 4.50%
Sandlot Buyer, LLC (Prime Time Healthcare) 9,390,951 Healthcare & Pharmaceuticals First Lien Debt S + 6.25%
Smile Brands Inc. 9,390,191 Healthcare & Pharmaceuticals Subordinated Debt S + 8.50%
Sandlot Buyer, LLC (Prime Time Healthcare) 7,758,729 Healthcare & Pharmaceuticals First Lien Debt S + 6.25%

1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at March 31, 2025. As of March 31, 2025, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 4.32%, 4.29%, 4.19%, and 4.01% respectively. Certain investments are subject to a SOFR floor or may utilize an alternative reference rate such as U.S. Prime Rate (“P”). For fixed rate loans, a spread above a reference rate is not applicable.